Letteratura scientifica selezionata sul tema "Α1-3-Galactose"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Α1-3-Galactose".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "Α1-3-Galactose":
Quinn, Gary, James C. Wood, David J. J. Ryan, Kristen M. Suling, Kathleen M. Moran, Donna L. Kolber-Simonds, Julia L. Greenstein, Henk-Jan Schuurman, Robert J. Hawley e Clive Patience. "Porcine Endogenous Retrovirus Transmission Characteristics of Galactose α1-3 Galactose-Deficient Pig Cells". Journal of Virology 78, n. 11 (1 giugno 2004): 5805–11. http://dx.doi.org/10.1128/jvi.78.11.5805-5811.2004.
Gabrielli, Armando, Pietro Leoni, Giovanni Danieli, Konrad Herrmann, Thomas Krieg e Jorgen Wieslander. "Antibodies against galactosyl (α1→3) galactose in connective tissue diseases". Arthritis & Rheumatism 34, n. 3 (marzo 1991): 375–76. http://dx.doi.org/10.1002/art.1780340321.
Hung, Le Dinh, e Le Thi Doan Thuc. "High-mannose type N-glycan binding specificity of a novel lectin from the red alga (Betaphycus gelatinus)". Vietnam Journal of Biotechnology 17, n. 4 (2 novembre 2020): 709–18. http://dx.doi.org/10.15625/1811-4989/17/4/13697.
Manez, R., I. Diaz, A. Centeno, E. Gonzalez, M. Hermida, F. Blanco, H. Ff Davies e A. Katopodis. "Sustained decrease of serum anti-galactose α1–3-galactose antibodies in baboons by removing aerobic gram-negative bacteria from the bowel". Transplantation Proceedings 31, n. 1-2 (febbraio 1999): 947–48. http://dx.doi.org/10.1016/s0041-1345(98)01849-1.
LAUDER, M. Robert, N. Thomas HUCKERBY, A. Ian NIEDUSZYNSKI e H. K. Anna PLAAS. "Age-related changes in the structure of the keratan sulphate chains attached to fibromodulin isolated from articular cartilage". Biochemical Journal 330, n. 2 (1 marzo 1998): 753–57. http://dx.doi.org/10.1042/bj3300753.
Li, Jun, Hui-Chen Hsu, Ping-Ar Yang, Qi Wu e John Mountz. "Fucosylation regulates cell death in rheumatoid arthritis (87.24)". Journal of Immunology 184, n. 1_Supplement (1 aprile 2010): 87.24. http://dx.doi.org/10.4049/jimmunol.184.supp.87.24.
Lee, Chan Hyoung, Hee Taek Kim, Eun Ju Yun, Ah Reum Lee, Sa Rang Kim, Jae-Han Kim, In-Geol Choi e Kyoung Heon Kim. "A Novel Agarolytic β-Galactosidase Acts on Agarooligosaccharides for Complete Hydrolysis of Agarose into Monomers". Applied and Environmental Microbiology 80, n. 19 (18 luglio 2014): 5965–73. http://dx.doi.org/10.1128/aem.01577-14.
Nakahashi, Hiromitsu, Tatsuya Oda, Osamu Shimomura, Yoshimasa Akashi, Kazuhiro Takahashi, Yoshihiro Miyazaki, Tomoaki Furuta et al. "Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations". Journal of Oncology 2024 (18 marzo 2024): 1–12. http://dx.doi.org/10.1155/2024/1529449.
Hernàndez, Dimas E., Aaron Cohen, Denisse Fisher, Marı̀a Correnti e Ricardo Harner. "Antibody Levels against Galactosyl (α1 → 3) Galactose Epitopes in Cervical Mucus from Patients with Human Papillomavirus Infection". Gynecologic Oncology 84, n. 3 (marzo 2002): 374–77. http://dx.doi.org/10.1006/gyno.2001.6516.
Seo, Ho Seong, Robert T. Cartee, David G. Pritchard e Moon H. Nahm. "A New Model of Pneumococcal Lipoteichoic Acid Structure Resolves Biochemical, Biosynthetic, and Serologic Inconsistencies of the Current Model". Journal of Bacteriology 190, n. 7 (1 febbraio 2008): 2379–87. http://dx.doi.org/10.1128/jb.01795-07.
Tesi sul tema "Α1-3-Galactose":
Rousse, Juliette. "Influence des anticorps anti-Neu5Gc et anti-alpha-1-3-Galactose dans la réponse immunitaire". Electronic Thesis or Diss., Nantes, Ecole nationale vétérinaire, 2019. http://www.theses.fr/2019ONIR134F.
During evolution, the human species has lost the ability to synthesize certain carbohydrates and sees its glycosylation of proteins and lipids modified compared to other mammals. Some glycosylated moieties acquired through the ingestion of food of animal origin or produced by the intestinal microbiota can be incorporated into our tissues and represent potential xeno-antigens that stimulate the production of antibodies. We are also exposed to these xeno-antigens when administering therapeutic proteins or when transplanting cells or tissues of animal origin. This is the case, for example, for polyclonal antibodies of animal origin. α1,3-Gal and Neu5Gc are two of these xeno-antigens that induce antibody responses in humans and are suspected of inducing allergies, serum diseases, inflammation and tumors. Among these antibodies, antilymphocytic sera of animal origin are widely used in induction treatment in kidney transplantation and have been tested in various indications including type 1 diabetes. This thesis aims to describe antibody responses against Neu5Gc and α-1,3-Gal in the context of rabbit serum antithymocyte treatments. The thesis also discusses the possible influence of these antibodies in the etiology of multiple sclerosis. The results show a quantitative and qualitative impact of rabbit antithymocyte serum administration on anti-Neu5Gc antibody responses, reveal a correlation between the level of these antibodies and the half-life of a kidney transplant, but did not allow to conclude as to their possible impact in other pathologies